Invesco’s Verona Pharma VRNA Stock Holding History

Invesco’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,062	Closed	-$327K	–	3874
2025 Q3	$327K	Sell	3,062 -35,177	-92%	-$3.67M	﹤0.01%	3385
2025 Q2	$3.62M	Buy	38,239 +34,943	+1,060%	+$2.59M	﹤0.01%	2341
2025 Q1	$209K	Buy	+3,296	New	+$197K	﹤0.01%	3494

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Invesco's VRNA Position: Q4 2025 in Review

Invesco sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 3,062 shares — an estimated $327K sold.

Invesco first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $3.62M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Invesco reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Invesco sold 3,062 Verona Pharma shares in Q4 2025, an estimated $327K.
Invesco first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
Invesco's Verona Pharma position peaked at $3.62M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Invesco's 13F filing for Q4 2025, filed 19 Feb 2026.